Sort
4,870 grants matching “glp 1”
Biorepository, Pathology, and Immune Monitoring Core
$307,969Kent J. Weinhold · Duke University · P50 · FY2019 · CA
The Effect of TCF7L2 on Glucose Metabolism
$307,409Adrian Vella · Mayo Clinic Rochester · R01 · FY2008 · DK
Neuroendocrine Integration of Satiety and Food Reward
$307,222Diana L Williams · Florida State University · R01 · FY2013 · DK
Role of taste signaling elements in enteroendocrine cells
$307,191Robert F Margolskee · Monell Chemical Senses Center · R01 · FY2012 · DK
Role of GLP-1 in Normal and Abnormal Glucose Tolerance
$307,000University Of Cincinnati · R01 · FY2005 · DK
Role of GLP-1 in Normal and Abnormal Glucose Tolerance
$307,000University Of Cincinnati · R01 · FY2004 · DK
Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
$306,872Calvin Carter · Geminii, Inc. · R43 · FY2025 · DK
Scalable Non-viral Gene Delivery for Neuromuscular Diseases
$306,859Martin K. Childers · Kinea Bio, Inc. · R44 · FY2025 · AR
Developing a topical beta blocker formulation as a targeted therapeutic for infantile hemangioma
$306,804Seth Reno · Arkayli Biopharma, Inc. · R41 · FY2025 · HL
Synthesis and Target Identification of Potent GLP1 Secretagogues
$306,768Jimmy Wu · Dartmouth College · R01 · FY2015 · GM
Long acting PTH for hypoparathyroidism
$306,738Laura M Hales · Extend Biosciences, Inc. · R43 · FY2015 · DK
Synthesis and Target Identification of Potent GLP1 Secretagogues
$306,727Jimmy Wu · Dartmouth College · R01 · FY2016 · GM
Synthesis and Target Identification of Potent GLP1 Secretagogues
$306,687Jimmy Wu · Dartmouth College · R01 · FY2017 · GM
Synthesis and Target Identification of Potent GLP1 Secretagogues
$306,655Jimmy Wu · Dartmouth College · R01 · FY2018 · GM
Brainstem Esophageal-Gastric Reflexes
$306,642Richard C. Rogers · Lsu Pennington Biomedical Research Ctr · R01 · FY2007 · DK
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$306,500Richard A Cone · Mucommune, Llc · R44 · FY2021 · AI
A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
$306,499Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · AI
Reducing infections and blockage associated with long-term implantation of ventriculoperitoneal and related shunts
$306,315Kenneth Wynne · Wynnvision, Llc · R44 · FY2025 · NS
EGFRwt and EGFRvlll Dual-Specific Immunotoxin for Glioblastoma Multiforme
$306,146Darell D Bigner · Duke University · P01 · FY2016 · CA
Test of catestatin (CST) and its mimetic as a new therapy for type 2 diabetes (T2D)
$306,100Shandy Shahabi · Siraj Therapeutics Inc. · R43 · FY2023 · DK
DIET/GROWTH FACTOR MECHANISMS OF GUT ADAPTATION
$305,687Emory University · R01 · FY2004 · DK
RNA recognition by maternal gene silencers in nematodes
$305,663Sean Patrick Ryder · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · GM
Aging And The Pancreas
$305,630Josephine Egan · National Institute On Aging · ZIA · FY2022 · AG
PDX-1 REGULATION OF PANCREAS DEVELOPMENT/DIFFERENTIATION
$305,540Doris A. Stoffers · University Of Pennsylvania · P01 · FY2007 · DK
SBIR Phase I: Hemostatic Tough Adhesive Hydrogels for Advanced Biosurgery
$305,000Phoebe Kwon · Limax Biosciences, Inc. · · FY2025 · TIP